Clinical Trials Directory

Trials / Conditions / Lymphoblastic Leukemia, Acute Adult

Lymphoblastic Leukemia, Acute Adult

8 registered clinical trials studyying Lymphoblastic Leukemia, Acute Adult — 3 currently recruiting.

StatusTrialSponsorPhase
UnknownDual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage
NCT05429905
KK Women's and Children's HospitalPhase 1 / Phase 2
RecruitingCD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lym
NCT05648019
KK Women's and Children's HospitalPhase 2
RecruitingCARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic
NCT05043571
National University Hospital, SingaporePhase 1
RecruitingALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
NCT05038696
National University Hospital, SingaporePhase 1
CompletedBlinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)
NCT04554485
Institute of Hematology and Blood Transfusion, Czech RepublicPhase 2
Active Not RecruitingStudy of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT03155191
Takara Bio Inc.Phase 1 / Phase 2
UnknownSequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL
NCT02766868
Shanghai Jiao Tong University School of MedicinePhase 2
AvailableExpanded Access Program for OOS Obe-cel
NCT06799221
Autolus Limited—